SMSergei V. Mikhin

Sergei V. Mikhin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergei V. Mikhin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Results of combined minimally invasive surgical treatment and prevention of portal hemorrhages in patients with liver cirrhosis

    by A. V. Kitaeva, S. V. Mikhin, P. V. Mozgovoy, M. Yu. Lukovskov, E. S. Aleinikova, E. P. Stroganova, A. V. Lopushkov, E. S. Mikhin, А. В. Китаева, С. В. Михин, et al.

    The main objective in performing staged minimally invasive surgical correction of portal hypertension, as a basis for the prevention and treatment of portal bleeding, is the correct selection of initial and subsequent interventions while adhering to the concept of an individualized approach. Objective . To improve the outcomes of treatment and prevention of portal bleeding in patients with liver cirrhosis. Material and research methods . A comparative controlled study was conducted on the treatment outcomes of 295 patients with cirrhotic portal hypertension between 2006 and 2025. Group 1 ( n = 109) underwent staged combined minimally invasive surgical treatment and prevention of portal bleeding. Group 2 ( n = 84) consisted of patients who received only endoscopic methods. Group 3 ( n = 102) included patients who received only conservative therapy. Research results . The frequency of complications after endoscopic procedures didn’t depend on a history of bleeding and was the same in groups 1 and 2. The correlation between functional class and the development of complications after minimally invasive azygoportal disconnection ( n = 65) was not statistically significant ( p = 0.491). Inverse correlations were found between the initial sagittal size of the spleen and the baseline levels of thrombocytopenia and leukopenia in patients who received splenic blood flow reduction. After transjugular portosystemic shunting, regression of esophageal and gastric varices was noted in 81.58 % of cases ( p < 0.0001). The most common combination was endoscopic band ligation of esophageal varices, azygoportal disconnection surgery, and splenic blood flow reduction ( n = 21). The choice of the initial method depended on the presence or risk of bleeding. Group 3 had a much higher mortality (7 times higher) than group 2 ( p < 0.0001). In group 1, the mortality rate is 3 times lower than in group 2 ( p < 0.0001). Conclusion . The use of minimally invasive surgical correction of portal hypertension, following an individualized approach based on the predominant complication, allows for a reduction in mortality.

  • Open Access

    Comparative analysis and prediction of survival in patients with decompensated liver cirrhosis under various methods of treatment and prevention of portal bleeding

    by Sergei V. Mikhin, Михин Сергей Викторович, Anastasiya V. Kitaeva, Китаева Анастасия Владимировна, Vladimir S. Ufimtsev, Уфимцев Владимир Сергеевич, Mikhail Yu. Lukovskov, Луковсков Михаил Юрьевич, Elena S. Aleynikova, Алейникова Елена Сергеевна

    Mortality among recipients - patients with liver cirrhosis who are on the transplant waiting list, is 15–25 % per year. This circumstance determines the high importance of minimally invasive surgical interventions, which are not only a technically convenient bridge on the way to liver transplantation, but often the only feasible life-saving option for the patient. The aim of the study: Search for ways to predict non-transplant and recurrence-free survival of patients with liver cirrhosis with respect to portal bleeding after its staged minimally invasive surgical treatment and prevention. Research methodology: A controlled comparative study of the outcomes of minimally invasive surgical treatment and prevention of portal bleeding in 295 patients with liver cirrhosis over the period 2006–2025 was conducted. All patients with liver cirrhosis were divided into three groups depending on the management strategy for liver lesions: main group (group 1) – 109 patients who received minimally invasive combined surgical treatment; comparison group (group 2) – 84 people who underwent various types of endoscopic correction; and control group (group 3), which included the results of conservative treatment in 102 patients. Short-term outcomes were assessed up to 6 months, medium-term outcomes up to 5 years, and long-term outcomes over 5 years among 142/295 patients (48.1 %). The results of the research: The application of combined minimally invasive surgical treatment and prophylaxis demonstrates the best survival outcomes compared to the use of only endoscopic or conservative therapy. Two models were obtained for predicting transplant-free and recurrence-free (regarding portal bleeding) survival in patients with liver cirrhosis after undergone minimally invasive surgical treatment and portal bleeding prophylaxis. Conclusions: The obtained methods for calculating the survival times of patients with liver cirrhosis after surgical correction of portal hypertension can be applied in the form of a mobile application for the most accurate determination of transplant-free and recurrence-free (in relation to portal bleeding) survival time while being on the liver transplant 'waiting list'.

  • Non-cirrhotic portal hypertension complicated by portal biliopathy

    by S.V. Mikhin, P.V. Mozgovoy, V.V. Mandrikov, A.V. Kitaeva, M.YU. Lukovskov

    The earliest references to association between mechanical jaundice and non-cirrhotic portal hypertension (NCPH) are by Fraser et al. (1944) and Gibson et al. (1965). The term “portal hypertension biliopathy” was proposed by Dhiman et al. (1999). The incidence of asymptomatic form of portal hypertension biliopathy (PHB) in patients with NCPH ranges from 81% to 100% that is significantly higher compared to patients with hepatic block (0—33%). Symptomatic form of PHB occurs only in 5—33% of patients. Any intervention on biliary tract in patients with PHB may result in significant blood loss due to coagulopathy. Currently, there is no consensus on optimal treatment algorithm for patients with symptomatic PHB. The authors present several patients with PHB complicated by mechanical jaundice and variants for correction of this complication.

  • Issues of endoscopic diagnosis and treatment for complications of portal hypertension

    by S.V. Mikhin, P.V. Mozgovoy, V.V. Mandrikov, A.V. Kitaeva, L.V. Sharashkina, I.V. Mikhin

    In addition to its recognized efficacy, endoscopic band ligation (EBL) of esophageal varices can lead to a number of complications, among which post-banding ulcer bleeding (PUB) has a special place. Model of end-stage liver disease >18 index in combination with emergency EBL has been found to be the most likely predictor of PUB. The choice of effective endoscopic treatment for gastric variceal (GV) is often reduced to endoscopic interventional techniques. Here, the choice of intervention under the control of endoscopic ultrasound scanning (EUS) has shown its superiority over traditional endoscopic and X-ray endovascular methods of treating. Standard EBL and endoscopic sclerotherapy (ES) have a higher complication rate in the treatment of gastrointestinal ectopic varices (GEV). Bypass surgeries do not always achieve eradication or regression of GEV. The use of EUS allows delineation of afferent vessels for direct injection of sclerosant, which is not feasible with conventional endoscopic treatment. The main causes of non-variceal portal bleeding are portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE). New minimally invasive diagnostic methods allow to differentiate PGH and GAVE with high specificity, and can help in understanding the etiopathogenesis of GAVE and finding effective ways of its treatment.

  • Trends in endovascular treatment and prevention of portal bleeding

    by S.V. Mikhin, P.V. Mozgovoy, A.V. Kitaeva, D.E. Gorbunov, I.V. Mikhin

    Bleeding from esophageal and gastric varices is a major factor of mortality in patients with portal hypertension. The gold standard for diagnosis of portal hypertension is hepatic venous pressure gradient determining the treatment algorithms and risk of recurrent bleeding. Combination of endoscopic methods and therapy is limited by varix localization and not always effective. In these cases, endovascular bypass and decoupling techniques are preferred. Early endovascular treatment of portal bleeding is effective for hemostasis and higher transplantation-free survival of patients. Early transjugular intrahepatic portosystemic bypass should be associated with 8-mm covered stents of controlled dilation. Combination of endovascular techniques reduces the complications of each technique and potentiates their positive effect. Endovascular treatment and prevention of portal bleeding should be determined by anatomical features of portal venous system.